You are here: Industry Insights > favipiravir

News List

Glenmark Begins Phase III Trial of Anti-Viral Combo in COVID-19 contractpharma
May 27, 2020
To test the combined efficacy of two antiviral drugs Favipiravir and Umifenovir as a potential COVID-19 treatment.
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India expresspharma
May 26, 2020
Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India.
Hikal announces development of Favipiravir APIs and its intermediates expresspharma
May 15, 2020
The company is in discussion with potential partners to supply the API and its intermediates.
Appili Therapeutics submits CTA with Health Canada to sponsor trial of favipiravir as preventative m pharmaceutical-business-review
May 14, 2020
Appili Therapeutics said that it will sponsor the first clinical trial evaluating FUJIFILM Toyama Chemical’s (FFTC) drug favipiravir for the prevention of COVID-19, a respiratory infection caused by the novel SARS-CoV-2 coronavirus.
Russia claims Favipiravir shows promise against coronavirus in early trials expresspharma
May 14, 2020
Favipiravir is also undergoing trials in India by Glenmark Pharmaceuticals.
Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir expresspharma
May 13, 2020
Over 10 leading government and private hospitals in India are being enrolled for the study, Glenmark estimates study completion by July/August 2020.
IICT develops synthetic process for Favipiravir, transfers to Cipla expresspharma
May 05, 2020
As a collaborative effort with industry, Hyderabad-based CSIR-IICT transferred the entire process and significant quantities of pharma grade API of Favipiravir to Cipla.
CSIR identifies top 25 drugs/drug candidates for repurposing expresspharma
May 04, 2020
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs.
DCGI approves Glenmark’s clinical trials of Favipiravir Antiviral tablets for COVID-19 patients expresspharma
April 30, 2020
The product is a generic version of Avigan of Fujifilm Toyama Chemical, Japan, a subsidiary of Fujifilm Corporation.
How Fette Compacting China supports the Battle against COVID-19 PhamraSources.com
April 30, 2020
The global pandemic of COVID-19 has changed the focus towards epidemic prevention and control of the infection in all areas of the world.

Previous page 1 2 3 4 5 6 Next page